Second Sight Medical (NSDQ:EYES) announced today that it took steps to reduce overhead and conserve liquidity ahead of potential partnering, acquiring, or combining with businesses. The maker of visual prosthetic implants for blind individuals announced last month that it was winding down its operations amid the financial shock of the coronavirus pandemic. At the time, Second […]
Neuromodulation/Neurostimulation
NeuroMetrix dips on Q1 losses
NeuroMetrix (NSDQ:NURO) shares fell today on first-quarter losses that reflected the impact of COVID-19 on its business. The Woburn, Mass.-based pain-treating transcutaneous electrical nerve stimulation (TENS) device developer posted losses of -$657,371 on sales of $2.2 million for the three months ended March 31, 2020, seeing its bottom line slide into the red from profits of […]
Axonics wins FDA approval for next-gen neurostimulator
Axonics Modulation Technologies (NSDQ:AXNX) announced today that it received FDA approval for its next-generation rechargeable neurostimulator for its r-SNM system. The Irvine, Calif.-based company’s r-SNM system is an implantable sacral neuromodulation (SNM) device for treating urinary and bowel dysfunction. Its most recent regulatory win came in January when the FDA approved a second-generation programmer for the […]
Pulse plans to seek $30m from investors
Pulse Biosciences (NSDQ:PLSE) announced it has filed a registration statement to raise approximately $30 million from existing shareholders. The rights offering will be made through the distribution of non-transferable subscription rights to purchase shares of the Hayward, Calif-based company’s common stock. The final price has not been set. Pulse Biosciences said it will use the proceeds […]
Nevro raising more than $300m through public offering, convertible senior notes
Nevro (NYSE:NVRO) announced today that it priced concurrent underwritten public offerings of more than 1.6 million common stock shares, as well as convertible senior notes, to raise more than $300 million. The offering of 1,625,000 total shares of common stock at a price of $84.00 per share is slated to bring gross proceeds of approximately $136.5 […]
BREAKING: Second Sight Medical laying off most of its workers, winding down
Second Sight Medical (NSDQ:EYES) announced today that it will wind down its operations amid the financial shock of the coronavirus pandemic. The Los Angeles–based company will lay off 84 of its 108 employees and will retain an adviser experienced in winding down operations to guide the board on the next steps. Company officials expect additional layoffs. […]
ElectroCore selling up to $25m in stock to Lincoln Park
ElectroCore (NSDQ:ECOR) announced today that it entered into a purchase agreement in which the neuroscience company has the right to sell shares of its common stock worth up to $25 million to Lincoln Park Capital Fund. Basking Ridge, N.J.-based ElectroCore would control the timing and amount of any sales of its common stock, valued at $0.001 […]
Neuromod Devices appoints Elsaesser as CCO
Non-invasive neuromodulation technology developer Neuromod Devices announced today that it is appointing Florian Elsaesser as its new chief commercial officer. Elsaesser is a 12-year veteran in the space, having worked extensively in the hearing aid industry, according to a news release. He previously held executive positions at Sivantos and Siemens (NYSE:SI) Audiology. Dublin-based Neuromod Devices said […]
LivaNova lands CE Mark for depression neurostimulation treatment
LivaNova (NSDQ:LIVN) said today that its vagus nerve stimulation therapy for treatment-resistant depression has won the CE Mark in Europe. Two patients in the United Kingdom were implanted with the company’s Symmetry system at the Musgrove Park Hospital in Taunton, England, making them the first patients to receive Symmetry devices outside the United States. The ability […]
NeuroPace wins FDA approval of MRI labeling for its neurostim system
NeuroPace announced today that FDA approval of MRI labeling for its RNS system for people living with seizures that do not respond to medication. The Mountain View, Calif.–based company touts its RNS system as the world’s only closed-loop brain-responsive neurostimulation system designed to prevent seizures at their source. It includes a neurostimulator, leads placed at […]
Neuronetics president and CEO stepping down
Neuronetics (NSDQ:STIM) recently announced that president and CEO Christopher Thatcher would be stepping down, effective immediately. Thatcher also resigned as director of the board of directors and his employment is expected through May 1. He will continue to provide transition services and advice to the company. Neuronetics said that Thatcher’s resignation was a mutual agreement and […]